BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 30806885)

  • 1. Targeting epigenetics for cancer therapy.
    Park JW; Han JW
    Arch Pharm Res; 2019 Feb; 42(2):159-170. PubMed ID: 30806885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecular modulators of cancer-associated epigenetic mechanisms.
    Itoh Y; Suzuki T; Miyata N
    Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and cancer.
    Kanwal R; Gupta S
    J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epigenetics and cancer].
    Xue C; Yu J; Liu H; Chen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1133-6. PubMed ID: 19947505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of cancer epigenetics.
    Jones PA
    Semin Hematol; 2005 Jul; 42(3 Suppl 2):S3-8. PubMed ID: 16015502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise of epigenetic therapy: reprogramming the cancer epigenome.
    Kelly AD; Issa JJ
    Curr Opin Genet Dev; 2017 Feb; 42():68-77. PubMed ID: 28412585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; CalabrĂ² L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer epigenetics: Linking basic biology to clinical medicine.
    Shinjo K; Kondo Y
    Adv Drug Deliv Rev; 2015 Dec; 95():56-64. PubMed ID: 26494398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
    Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
    Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting DNA methylation in cancer.
    Szyf M
    Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.